You just read:

Janssen's INVOKANA (canagliflozin) Gets Boost Over Competitors with FDA Approval for Diabetic Kidney Disease and a Newly Minted Collaboration with Renal Giant, Vifor Pharma

News provided by

Spherix Global Insights

Nov 25, 2019, 17:07 ET